跳至主要内容
临床试验/NCT05338008
NCT05338008已完成不适用

Serum and Wound Vancomycin Levels Following Intrawound Administration in Primary Total Hip Arthroplasty

The Affiliated Hospital of Qingdao University1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2022年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
120
试验地点
1
主要终点
Blood loss

研究概览

简要总结

The purpose of this study is to determine the intra-articular and serum levels of vancomycin over the first 24 hours postoperatively after intra-articular administration of a standard dose of vancomycin in primary total hip arthroplasty.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age over 18;
  • Total hip arthroplasty for advanced hip diseases including femoral neck fracture, developmental dysplasia of hip, and osteonecrosis of the femoral head.

排除标准

  • Diminished mental capacity
  • Vancomycin allergy
  • Chronic kidney disease stage III and stage IV

结局指标

主要结局

Blood loss

时间窗: Postoperative Day 3

Renal function

时间窗: Postoperative Day 1 and Day 3

blood urea nitrogen (BUN), creatinine (Cr), GFR

Intra-articular vancomycin concentration

时间窗: 2 hours, 8 hours and 24 hours postoperatively

Serum vancomycin concentration

时间窗: 2 hours, 8 hours and 24 hours postoperatively

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Xiang Shuai, MD

Principal Investigator

The Affiliated Hospital of Qingdao University

研究点 (1)

Loading locations...

相似试验